Toward Cannabinoid Use for Refractory Cutaneous Dermatomyositis. Wittmann M, Staubach P, McGonagle D. J Invest Dermatol 2022;142:2556-2557.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wittmann M, Staubach P, McGonagle D. Toward Cannabinoid Use for Refractory Cutaneous Dermatomyositis. J Invest Dermatol 2022;142:2556-2557.
PMID: 36153061